HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R Du Selected Research
R Du Research Topics
Disease
5
Neoplasms (Cancer)
01/2012 - 09/2000
4
Hepatocellular Carcinoma (Hepatoma)
02/2008 - 09/2000
3
Portal Hypertension
05/2000 - 02/2000
2
Cerebral Infarction
11/2020 - 01/2015
2
Lung Neoplasms (Lung Cancer)
01/2009 - 09/2008
2
Neoplasm Metastasis (Metastasis)
01/2009 - 02/2007
2
Infections
02/2007 - 12/2000
1
Brain Ischemia (Cerebral Ischemia)
11/2020
1
Virus Diseases (Viral Diseases)
01/2018
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2016
1
Hypoxia (Hypoxemia)
11/2016
1
Embolism (Embolus)
01/2015
1
Infarction (Infarctions)
01/2015
1
Coronary Artery Disease (Coronary Atherosclerosis)
10/2014
1
Tetraploidy
04/2014
1
Asthma (Bronchial Asthma)
04/2013
1
Papillomavirus Infections
01/2013
1
Rheumatic Fever (Acute Articular Rheumatism)
01/2013
1
Uterine Cervical Dysplasia
01/2012
1
Carcinoma (Carcinomatosis)
01/2012
1
Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2011
1
Brain Injuries (Brain Injury)
12/2011
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2008
1
Stomach Neoplasms (Stomach Cancer)
01/2008
1
Hepatitis B
02/2007
1
Erectile Dysfunction
12/2000
1
Coronary Stenosis (Coronary Artery Stenosis)
12/2000
1
Hepatitis E
12/2000
1
Hyperemia
11/2000
1
Coronary Occlusion
11/2000
1
Melanoma (Melanoma, Malignant)
09/2000
1
Fibrosis (Cirrhosis)
09/2000
1
Carcinogenesis
09/2000
1
Ascites
02/2000
Drug/Important Bio-Agent (IBA)
4
Messenger RNA (mRNA)
IBA
02/2007 - 05/2000
3
Proteins (Proteins, Gene)
FDA Link
11/2016 - 05/2000
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2016 - 01/2015
2
Cytokines
IBA
01/2012 - 01/2008
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2009 - 09/2008
2
ErbB Receptors (EGF Receptor)
IBA
01/2009 - 09/2008
2
Sildenafil Citrate (Viagra)
FDA Link
12/2000 - 11/2000
2
Antigens
IBA
12/2000 - 09/2000
2
Nitric Oxide (Nitrogen Monoxide)
FDA Link
11/2000 - 02/2000
1
Neuroprotective Agents
IBA
11/2020
1
triphenyltetrazolium
IBA
11/2020
1
Nucleic Acids
IBA
01/2018
1
Valproic Acid (Depakote)
FDA Link
Generic
11/2016
1
Histone Deacetylase Inhibitors
IBA
11/2016
1
Bromodeoxyuridine (BrdU)
IBA
01/2015
1
Laminin (Merosin)
IBA
01/2015
1
Integrins
IBA
01/2015
1
MEF2 Transcription Factors
IBA
10/2014
1
Mitochondrial DNA (mtDNA)
IBA
04/2014
1
Pharmaceutical Preparations
IBA
04/2013
1
Bronchodilator Agents (Bronchodilators)
IBA
04/2013
1
Nitroprusside (Sodium Nitroprusside)
FDA Link
Generic
01/2013
1
Oxides
IBA
01/2013
1
Transforming Growth Factor beta (TGF-beta)
IBA
01/2012
1
Interleukin-10 (Interleukin 10)
IBA
01/2012
1
Biomarkers (Surrogate Marker)
IBA
12/2011
1
Endothelin-1 (Endothelin 1)
IBA
12/2011
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
12/2011
1
Matrix Metalloproteinases (MMPs)
IBA
12/2011
1
Gefitinib (Iressa)
FDA Link
01/2009
1
((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)
IBA
09/2008
1
Notch Receptors
IBA
02/2008
1
RNA (Ribonucleic Acid)
IBA
02/2008
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
02/2008
1
Biological Products
IBA
01/2008
1
Small Interfering RNA (siRNA)
IBA
01/2008
1
multidrug resistance-associated protein 1
IBA
01/2008
1
HLA-DRB1 Chains (HLA DRB1)
IBA
02/2007
1
HLA-DRB1*07 antigen
IBA
02/2007
1
Osteopontin
IBA
02/2007
1
DNA (Deoxyribonucleic Acid)
IBA
07/2001
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
07/2001
1
Epitopes
IBA
12/2000
1
Recombinant Proteins
IBA
12/2000
1
Indicators and Reagents (Reagents)
IBA
09/2000
1
Protein Subunit Vaccines
IBA
09/2000
1
Adrenergic Receptors (Adrenergic Receptor)
IBA
05/2000
1
Cimetidine (Biomet)
FDA Link
Generic
04/2000
1
urapidil
IBA
04/2000
1
Endotoxins
IBA
02/2000
1
Albumins
IBA
02/2000
Therapy/Procedure
3
Therapeutics
11/2016 - 01/2009
1
Kidney Transplantation
01/2018
1
Transplantation
01/2018
1
Sutures (Suture)
01/2015
1
Aftercare (After-Treatment)
01/2013
1
Immunotherapy
09/2000